SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Eocene Ltd. Ordinary Shares

EOCN XNAS
$1.78 +0.03 (+1.73%) ▲ 15-min delayed
Open
$1.84
High
$1.96
Low
$1.78
Volume
9.2K
Market Cap
$1.90M

About Eocene Ltd. Ordinary Shares

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.

Employees: 6 Website →

Related Market News

No specific coverage for EOCN yet. Check out our latest market news or earnings calendar.

Get EOCN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Eocene Ltd. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.